Mar­ket­ingRx roundup: Phar­mas dou­ble down on re­new­able en­er­gy; Bay­er funds health eq­ui­ty re­search

At COP28 in Dubai on Mon­day, Schnei­der Elec­tric an­nounced a new co­hort of phar­ma com­pa­nies join­ing its now 2-year-old “En­er­gize” re­new­able en­er­gy pro­gram specif­i­cal­ly for life sci­ence com­pa­nies. New spon­sors in­clud­ing Boehringer In­gel­heim, Charles Riv­er, Roche, Mer­ck KgAA and Ha­le­on round out the now 20 com­pa­nies in five pow­er pur­chas­ing buy­ing groups across the EU, UK and North Amer­i­ca.

The newest mem­bers join the 10 found­ing phar­mas — As­traZeneca, Bio­gen, GSK, John­son & John­son, Mer­ck/MSD, No­var­tis, No­vo Nordisk, Pfiz­er, Sanofi and Take­da — in work­ing to­geth­er to tran­si­tion their sup­ply chains to re­new­able en­er­gy sources.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER